Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure.

Source:http://linkedlifedata.com/resource/pubmed/id/11808823

Download in:

View as

General Info

PMID
11808823